Dipeptidyl peptidase-4 inhibitors reduce the incidence of first cardiovascular events in Japanese diabetic patients

Hirofumi Soejima(Kumamoto Health Science University), Mayumi Kiyota, Makoto Ikemura, Kazuo Gotō, Yoshiko Shioya, Shinya Yumoto, Izuru Masuda(Takeda (Japan)), Eiitiro Tanaka, Sadanori Okada(Hyogo Medical University), Masako Waki(Shizuoka City Hospital), Masafumi Nakayama(Kumamoto University), Kenichi Ashihara, Satoshi Tanazawa, Isao Yasuda, Takeshi Morimoto(Hyogo Medical University), Yoshihiro Kimura, Kenichi Doijiri, Yoshihiko Saito(National Archives and Records Administration), Genshi Egusa(National Institutes of Health), Osamu Haraguchi, Seigo Sugiyama(Diabetes Care Center), Chieko Imamoto, Norifumi Kondo, Ken Iwai(Kumamoto University), Atsushi Hasegawa, Michio Shimabukuro(Fukushima Medical University), Yutaka Mitsudo, Kazuhiko Yamada, Kazunobu Akahoshi, Hideaki Jinnouchi(Kumamoto University Hospital), Chisa Matsumoto(Brigham and Women's Hospital), Kimiaki Miwa, Toshiya Atsumi(Feinstein Institute for Medical Research), Hirofumi Kan(National Center for High-Performance Computing), Haruo Araki, Yosuke Shioya, Yoshikuni Haraguchi, Masashi Horimoto, Yoichi Hanaoka, Yoshihisa Iseri, Masanori Kamura, Shinya Okamoto, Ryo Fukami, Osamu Doi(Shizuoka General Hospital), Tsuneo Ikeda, Kenji Misumi, Yutaka Horio, Hisao Ogawa(Kumamoto University Hospital)
Heart and Vessels
July 31, 2023
Cited by 12


Related Papers